Annual report pursuant to Section 13 and 15(d)

Segment reporting (Details) - Schedule of segment reporting information, by segment

v3.3.0.814
Segment reporting (Details) - Schedule of segment reporting information, by segment - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2015
Jul. 31, 2015
Jul. 31, 2014
Jul. 31, 2013
Revenues:        
Clinical laboratory services   $ 63,414 $ 58,689 $ 55,889
Product revenues   31,690 32,850 32,526
Royalty and license fee income   2,495 4,408 5,292
Total revenues   97,599 95,947 93,707
Operating expenses:        
Cost of clinical laboratory services   39,589 38,948 38,251
Cost of product revenues   15,183 15,320 16,584
Research and development   3,350 3,141 3,889
Selling, general and administrative   41,069 41,801 43,654
Provision for uncollectible accounts receivable   2,284 3,063 4,496
Legal fee expense   8,788 6,954 5,813
Legal settlements, net $ (170) (11,458) (3,100)  
Operating (loss) income   (1,206) (10,180) (18,980)
Other income (expense)        
Other   95 194 5
Foreign exchange gain   (936) 289 80
Clinical Labs [Member]        
Revenues:        
Clinical laboratory services   63,414 58,689 55,889
Total revenues   63,414 58,689 55,889
Operating expenses:        
Cost of clinical laboratory services   39,589 38,948 38,251
Research and development     14 294
Selling, general and administrative   20,666 20,460 19,942
Provision for uncollectible accounts receivable   2,418 3,115 4,232
Legal fee expense   196 736 316
Legal settlements, net     2,000  
Total operating expenses   62,869 65,273 63,035
Operating (loss) income   545 (6,584) (7,146)
Other income (expense)        
Interest   (86) (43) (46)
Other   28 56 49
(Loss) income before income taxes   487 (6,571) (7,143)
Depreciation and amortization included above   1,443 1,415 1,377
Share-based compensation included in above:        
Capital expenditures   1,557 643 757
Life Sciences [Member]        
Revenues:        
Product revenues   31,690 32,850 32,526
Royalty and license fee income   2,495 4,408 5,292
Total revenues   34,185 37,258 37,818
Operating expenses:        
Cost of product revenues   15,183 15,320 16,584
Research and development   2,608 2,350 2,356
Selling, general and administrative   12,168 13,374 15,511
Provision for uncollectible accounts receivable   (134) (52) 264
Legal fee expense   (67) 940 57
Legal settlements, net   (11,458) (5,100)  
Total operating expenses   18,300 26,832 34,772
Operating (loss) income   15,885 10,426 3,046
Other income (expense)        
Interest   10 9 13
Other   9 95 (71)
Foreign exchange gain   (936) 289 80
(Loss) income before income taxes   14,968 10,819 3,066
Depreciation and amortization included above   2,254 2,455 3,102
Share-based compensation included in above:        
Capital expenditures   226 195 231
Therapeutics [Member]        
Operating expenses:        
Research and development   742 777 1,239
Total operating expenses   742 777 1,239
Operating (loss) income   (742) (777) (1,239)
Other income (expense)        
(Loss) income before income taxes   (742) (777) (1,239)
Depreciation and amortization included above   3 7 22
Other Segments [Member]        
Operating expenses:        
Selling, general and administrative   8,235 7,967 8,201
Legal fee expense   8,659 5,278 5,440
Total operating expenses   16,894 13,245 13,641
Operating (loss) income   (16,894) (13,245) (13,641)
Other income (expense)        
Interest   (169) (174) (21)
Other   58 43 27
(Loss) income before income taxes   (17,005) (13,376) (13,635)
Depreciation and amortization included above   89 94 104
Consolidated [Member]        
Revenues:        
Clinical laboratory services   63,414 58,689 55,889
Product revenues   31,690 32,850 32,526
Royalty and license fee income   2,495 4,408 5,292
Total revenues   97,599 95,947 93,707
Operating expenses:        
Cost of clinical laboratory services   39,589 38,948 38,251
Cost of product revenues   15,183 15,320 16,584
Research and development   3,350 3,141 3,889
Selling, general and administrative   41,069 41,801 43,654
Provision for uncollectible accounts receivable   2,284 3,063 4,496
Legal fee expense   8,788 6,954 5,813
Legal settlements, net   (11,458) (3,100)  
Total operating expenses   98,805 106,127 112,687
Operating (loss) income   (1,206) (10,180) (18,980)
Other income (expense)        
Interest   (245) (208) (54)
Other   95 194 5
Foreign exchange gain   (936) 289 80
(Loss) income before income taxes   (2,292) (9,905) (18,949)
Depreciation and amortization included above   3,789 3,971 4,605
Share-based compensation included in above:        
Capital expenditures   1,783 838 988
Cost of Clinical Laboratory Services [Member] | Clinical Labs [Member]        
Share-based compensation included in above:        
Share-based compensation   5 8 9
Cost of Clinical Laboratory Services [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation     1 1
Cost of Clinical Laboratory Services [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation   5 9 10
Research and Development Expense [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation   2 1 2
Research and Development Expense [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation   2 1 2
Selling, General and Administrative Expenses [Member] | Clinical Labs [Member]        
Share-based compensation included in above:        
Share-based compensation   43 36 36
Selling, General and Administrative Expenses [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation   15 6 10
Selling, General and Administrative Expenses [Member] | Other Segments [Member]        
Share-based compensation included in above:        
Share-based compensation   364 542 487
Selling, General and Administrative Expenses [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation   422 584 533
Total [Member] | Clinical Labs [Member]        
Share-based compensation included in above:        
Share-based compensation   48 44 45
Total [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation   17 8 13
Total [Member] | Other Segments [Member]        
Share-based compensation included in above:        
Share-based compensation   364 542 487
Total [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation   $ 429 $ 594 $ 545